已收盘 02-06 16:00:00 美东时间
+0.625
+1.02%
Artivion Reports Strong Survival and Low Morbidity in NEXUS TRIOMPHE and AMDS PERSEVERE Trials Artivion Inc. has announced the presentation of new clinical data from two trials—the NEXUS TRIOMPHE IDE trial and the AMDS PERSEVERE IDE trial—at the 62nd Annual Meeting of the Society of Thoracic Surgeon
02-02 21:01
Jan 8 (Reuters) - Trio Petroleum Corp TPET.A: TRIO PETROLEUM CORP: ON JAN 2, BOARD FORMALLY TERMINATES PRESIDENT TERENCE B. ESCHNER TRIO PETROLEUM CORP: ON JAN 2, BOARD FORMALLY TERMINATES CHIEF OPERA...
2025-01-09 06:33